山東黃金(01787.HK):變更註冊資本
格隆匯 8 月 27日丨山東黃金(01787.HK)宣佈,於2020年8月27日,根據公司股東於2020年6月24日舉行的公司2019年股東周年大會、公司2020年第二次A股類別股東會議及公司2020年第二次H股類別股東會議上授予董事會的授權,根據《中華人民共和國公司法》等法律法規相關規定,董事會已批准因資本公積金轉股的方式按每十股股份獲發四股紅股的基準向全體股東(基於公司已發行合共3,099,611,632股股份)發行紅股而對公司的公司章程作出若干修訂。公司於2020年8月19日合共發行1,239,844,651股紅股,因此公司註冊資本由人民幣3,099,611,632元變更為人民幣4,339,456,283元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.